Cargando…
Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
Cardiovascular Diseases (CVs) are one of the main causes of mortality and disability around the world. Advances in drug treatment have greatly improved survival and quality of life in the past decades, but associated adverse events remain a relevant problem. Pharmacogenetics can help individualize c...
Autores principales: | García-González, Xandra, Salvador-Martín, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619366/ https://www.ncbi.nlm.nih.gov/pubmed/34834533 http://dx.doi.org/10.3390/jpm11111180 |
Ejemplares similares
-
Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022) -
Pharmacogenetics for severe adverse drug reactions induced by molecular‐targeted therapy
por: Udagawa, Chihiro, et al.
Publicado: (2020) -
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
por: García-González, Xandra, et al.
Publicado: (2023) -
Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011) -
Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)